chr6-110424938-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033125.4(SLC22A16):āc.1669A>Gā(p.Thr557Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,614,108 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A16 | NM_033125.4 | c.1669A>G | p.Thr557Ala | missense_variant | 8/8 | ENST00000368919.8 | NP_149116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A16 | ENST00000368919.8 | c.1669A>G | p.Thr557Ala | missense_variant | 8/8 | 1 | NM_033125.4 | ENSP00000357915 | P2 | |
SLC22A16 | ENST00000330550.8 | c.1567A>G | p.Thr523Ala | missense_variant | 10/10 | 1 | ENSP00000328583 | A2 | ||
SLC22A16 | ENST00000451557.5 | c.*418A>G | 3_prime_UTR_variant | 7/7 | 2 | ENSP00000395642 | ||||
SLC22A16 | ENST00000460159.1 | n.215A>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251472Hom.: 1 AF XY: 0.000272 AC XY: 37AN XY: 135910
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461886Hom.: 3 Cov.: 30 AF XY: 0.000199 AC XY: 145AN XY: 727242
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.1669A>G (p.T557A) alteration is located in exon 8 (coding exon 8) of the SLC22A16 gene. This alteration results from a A to G substitution at nucleotide position 1669, causing the threonine (T) at amino acid position 557 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at